Tuesday, November 5, 2024
HomeTagsATI-1645 Exhibit

ATI-1645 Exhibit

Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study

Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics